Talk Bio

Actionable Insights Powered by AI

Subscribe

Latozinemab

Alector’s GSK-partnered dementia drug latozinemab fails in late-stage trial

talkbio0Tagged , , , , , , , ,

Alector; GSK; latozinemab; dementia; frontotemporal dementia; Phase 3 trial; clinical trial failure; progranulin; drug development

Read More